ADC Therapeutics SA Number of Employees 2019-2022 | ADCT

ADC Therapeutics SA number of employees from 2019 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
ADC Therapeutics SA Annual Number of Employees
2021 312
2020 208
2019 179
2018
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.267B $0.034B
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $171.964B 10.49
GSK (GSK) United Kingdom $71.240B 8.93
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.458B 19.56
Ginkgo Bioworks Holdings (DNA) United States $3.841B 0.00
Myovant Sciences (MYOV) United Kingdom $2.593B 0.00
Arcus Biosciences (RCUS) United States $2.495B 37.46
Biohaven (BHVN) United States $1.127B 0.00
Emergent Biosolutions (EBS) United States $0.589B 4.63
Zymeworks (ZYME) Canada $0.487B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
SQZ Biotechnologies (SQZ) United States $0.052B 0.00
Gelesis Holdings (GLS) United States $0.025B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00